Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 6832685, 12 pages
https://doi.org/10.1155/2018/6832685
Review Article

The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility

1Department of Gynecology Minimally Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006, China
2Department of Obstetrics & Gynaecology, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, Hong Kong

Correspondence should be addressed to Hua Duan; moc.361@icsauhnaud

Received 9 August 2017; Accepted 18 January 2018; Published 15 March 2018

Academic Editor: William H. Catherino

Copyright © 2018 Jin-Jiao Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Vercellini, F. Parazzini, S. Oldani, S. Panazza, T. Bramante, and P. G. Crosignani, “Surgery: Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics,” Human Reproduction, vol. 10, no. 5, pp. 1160–1162, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Vavilis, T. Agorastos, J. Tzafetas et al., “Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors,” Clinical and Experimental Obstetrics & Gynecology, vol. 24, no. 1, pp. 36–38, 1997. View at Google Scholar · View at Scopus
  3. J. D. Seidman and K. H. Kjerulff, “Pathologic findings from the Maryland Women's Health Study: Practice patterns in the diagnosis of adenomyosis,” International Journal of Gynecological Pathology, vol. 15, no. 3, pp. 217–221, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Parazzini, P. Vercellini, S. Panazza, L. Chatenoud, S. Oldani, and P. G. Crosignani, “Risk factors for adenomyosis,” Human Reproduction, vol. 12, no. 6, pp. 1275–1279, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Bergholt, L. Eriksen, N. Berendt, M. Jacobsen, and J. B. Hertz, “Prevalence and risk factors of adenomyosis at hysterectomy,” Human Reproduction, vol. 16, no. 11, pp. 2418–2421, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. N. M. de Souza, J. J. Brosens, J. E. Schwieso, T. Paraschos, and R. M. L. Winston, “The potential value of magnetic resonance imaging in infertility,” Clinical Radiology, vol. 50, no. 2, pp. 75–79, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Kunz, D. Beil, P. Huppert, M. Noe, S. Kissler, and G. Leyendecker, “Adenomyosis in endometriosis—prevalence and impact on fertility: evidence from magnetic resonance imaging,” Human Reproduction, vol. 20, no. 8, pp. 2309–2316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kissler, S. Zangos, J. Kohl et al., “Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 137, no. 2, pp. 204–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Naftalin, W. Hoo, K. Pateman, D. Mavrelos, T. Holland, and D. Jurkovic, “How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic,” Human Reproduction, vol. 27, no. 12, pp. 3432–3439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Di Donato, G. Montanari, A. Benfenati et al., “Prevalence of adenomyosis in women undergoing surgery for endometriosis,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 181, pp. 289–293, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Bird, T. W. McElin, and P. Manalo-Estrella, “The elusive adenomyosis of the uterus-revisited,” American Journal of Obstetrics & Gynecology, vol. 112, no. 5, pp. 583–593, 1972. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Alabiso, L. Alio, S. Arena et al., “Adenomyosis: What the Patient Needs,” Journal of Minimally Invasive Gynecology, vol. 23, no. 4, pp. 476–488, 2016. View at Google Scholar
  13. G. Leyendecker, A. Bilgicyildirim, M. Inacker et al., “Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study,” Archives of Gynecology and Obstetrics, vol. 291, no. 4, pp. 917–932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Struble, S. Reid, and M. A. Bedaiwy, “Adenomyosis: a clinical review of a challenging gynecologic condition,” Journal of Minimally Invasive Gynecology, vol. 23, no. 2, pp. 164–185, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Benagiano, I. Brosens, and M. Habiba, “Structural and molecular features of the endomyometrium in endometriosis and adenomyosis,” Human Reproduction Update, vol. 20, no. 3, Article ID dmt052, pp. 386–402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Zhang, L. Zhou, T. C. Li, H. Duan, P. Yu, and H. Y. Wang, “Ultrastructural features of endometrial-myometrial interface and its alteration in adenomyosis,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 4, pp. 1469–1477, 2014. View at Google Scholar · View at Scopus
  17. H. Takeuchi, M. Kitade, I. Kikuchi, J. Kumakiri, K. Kuroda, and M. Jinushi, “Diagnosis, laparoscopic management, and histopathologic findings of juvenile cystic adenomyoma: A review of nine cases,” Fertility and Sterility, vol. 94, no. 3, pp. 862–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Levgur, M. A. Abadi, and A. Tucker, “Adenomyosis: symptoms, histology, and pregnancy terminations,” Obstetrics & Gynecology, vol. 95, no. 5, pp. 688–691, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Ozdegirmenci, F. Kayikcioglu, M. A. Akgul et al., “Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis,” Fertility and Sterility, vol. 95, no. 2, pp. 497–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. C. Benson and V. D. Sneeden, “Adenomyosis: A reappraisal of symptomatology,” American Journal of Obstetrics & Gynecology, vol. 76, no. 5, pp. 1044–1061, 1958. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Campo, V. Campo, and G. Benagiano, “Adenomyosis and infertility,” Reproductive BioMedicine Online, vol. 24, no. 1, pp. 35–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Kunz and G. Leyendecker, “Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction.,” Reproductive BioMedicine Online, vol. 4, pp. 5–9, 2002. View at Google Scholar · View at Scopus
  23. G. Benagiano, M. Habiba, and I. Brosens, “The pathophysiology of uterine adenomyosis: An update,” Fertility and Sterility, vol. 98, no. 3, pp. 572–579, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Tremellen and P. Russell, “Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 51, no. 3, pp. 280–283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Reinhold, M. Atri, A. Mehio, R. Zakarian, A. E. Aldis, and P. M. Bret, “Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography,” Radiology, vol. 197, no. 3, pp. 609–614, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Dueholm and E. Lundorf, “Transvaginal ultrasound or MRI for diagnosis of adenomyosis,” Current Opinion in Obstetrics and Gynecology, vol. 19, no. 6, pp. 505–512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-H. Chiang, M.-Y. Chang, J.-J. Hsu et al., “Tumor vascular pattern and blood flow impedance in the differential diagnosis of leiomyoma and adenomyosis by color Doppler sonography,” Journal of Assisted Reproduction and Genetics, vol. 16, no. 5, pp. 268–275, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Van den Bosch, M. Dueholm, F. P. Leone et al., “Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group,” Ultrasound in Obstetetrics Gynecology, vol. 46, no. 3, pp. 284–298, 2015. View at Google Scholar
  29. S. H. Saravelos, K. Jayaprakasan, K. Ojha, and T.-C. Li, “Assessment of the uterus with three-dimensional ultrasound in women undergoing ART,” Human Reproduction Update, vol. 23, no. 2, pp. 188–210, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Exacoustos, L. Brienza, and A. Di Giovanni, “Adenomyosis: three-dimensional sonographic findings of the JZ and correlation with histology,” Ultrasound in Obstetetrics & Gynecology, vol. 37, no. 4, pp. 471–479, 2011. View at Google Scholar
  31. F. Ahmadi and H. Haghighi, “Three-dimensional ultrasound manifestations of adenomyosis,” Iranian Journal of Reprodive Medicine, vol. 11, no. 10, pp. 847-848, 2013. View at Google Scholar
  32. C. Reinhold, F. Tafazoli, A. Mehio et al., “Uterine adenomyosis: Endovaginal US and MR imaging features with histopathologic correlation,” RadioGraphics, vol. 19, pp. S147–S160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Reinhold, S. McCarthy, P. M. Bret et al., “Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation,” Radiology, vol. 199, no. 1, pp. 151–158, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Champaneria, P. Abedin, J. Daniels, M. Balogun, and K. S. Khan, “Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: Systematic review comparing test accuracy,” Acta Obstetricia et Gynecologica Scandinavica, vol. 89, no. 11, pp. 1374–1384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Acar, E. Millar, M. Mitkova, and V. Mitkov, “Value of ultrasound shear wave elastography in the diagnosis of adenomyosis,” Ultrasound, vol. 24, no. 4, pp. 205–213, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. S. R. Soares, M. M. B. B. Dos Reis, and A. F. Camargos, “Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases,” Fertility and Sterility, vol. 73, no. 2, pp. 406–411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. C. R. Molinas and R. Campo, “Office hysteroscopy and adenomyosis,” Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 20, no. 4, pp. 557–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. McCausland, “Hysteroscopic myometrial biopsy: Its use in diagnosing adenomyosis and its clinical application,” American Journal of Obstetrics & Gynecology, vol. 166, no. 6 I, pp. 1619–1628, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Darwish, A. M. Makhlouf, A. A. Youssof, and H. A. Gadalla, “Hysteroscopic myometrial biopsy in unexplained abnormal uterine bleeding,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 86, no. 2, pp. 139–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. L. W. Popp, J. P. Schwiedessen, and R. Gaetje, “Myometrial biopsy in the diagnosis of adenomyosis uteri,” American Journal of Obstetrics Gynecology, vol. 169, p. 546, 1993. View at Publisher · View at Google Scholar
  41. S. Gordts, R. Campo, and I. Brosens, “Hysteroscopic diagnosis and excision of myometrial cystic adenomyosis,” Journal of Gynecologic Surgery, vol. 11, no. 4, pp. 273–278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. C.-J. Jeng, S.-H. Huang, J. Shen, C.-S. Chou, and C.-R. Tzeng, “Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis,” Human Reproduction, vol. 22, no. 7, pp. 2016–2019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. C. Gambone, B. S. Mittman, M. G. Munro, A. R. Scialli, and C. A. Winkel, “Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process,” Fertility and Sterility, vol. 78, no. 5, pp. 961–972, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Vercellini, G. Frontino, O. De Giorgi, G. Pietropaolo, R. Pasin, and P. G. Crosignani, “Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen,” Fertility and Sterility, vol. 80, no. 3, pp. 560–563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Mansouri, X. M. Santos, J. L. Bercaw-Pratt, and J. E. Dietrich, “Regression of Adenomyosis on Magnetic Resonance Imaging after a Course of Hormonal Suppression in Adolescents: A Case Series,” Journal of Pediatric & Adolescent Gynecology, vol. 28, no. 6, pp. 437–440, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Igarashi, M. Fukuda, A. Ando et al., “Local administration of danazol on pelvic endometriosis and uterine adenomyosis , Nihon Rinsho,” Japanese Journal of Clinical Medicine, vol. 59, supplement 1, pp. 153–156, 2001. View at Google Scholar
  47. M. Igarashi, Y. Abe, M. Fukuda et al., “Erratum: Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device (Fertility and Sterility (2000) 74 (412- 413)),” Fertility and Sterility, vol. 74, no. 4, p. 851, 2000. View at Google Scholar · View at Scopus
  48. M. Fawzy and Y. Mesbah, “Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial,” Archives of Gynecology and Obstetrics, vol. 292, no. 6, pp. 1267–1271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Ji, X. H. Yang, A. L. Ai Xing, T. X. Zi, Y. He, and Y. Ding, “Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function,” Clinical and Experimental Obstetrics & Gynecology, vol. 41, no. 6, pp. 677–680, 2014. View at Google Scholar
  50. O. M. Shaaban, M. K. Ali, A. M. A. Sabra, and D. E. M. Abd El Aal, “Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: A randomized clinical trial,” Contraception, vol. 92, no. 4, pp. 301–307, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Zhang, K. Song, L. Li, K. Yukuwa, and B. Kong, “Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis,” Medical Principles and Practice, vol. 22, no. 5, pp. 480–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Zheng, E. Xia, T. C. Li, and X. Sun, “Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: A prospective clinical trial,” The Journal of Reproductive Medicine, vol. 58, no. 7-8, pp. 285–290, 2013. View at Google Scholar · View at Scopus
  53. F.-J. Huang, F.-T. Kung, S.-Y. Chang, and T.-Y. Hsu, “Effects of short-course buserelin therapy on adenomyosis: A report of two cases,” Obstetrics, Gynaecology and Reproductive Medicine, vol. 44, no. 8, pp. 741–744, 1999. View at Google Scholar · View at Scopus
  54. K. H. Tsui, W. L. Lee, C. Y. Chen et al., “Medical treatment for adenomyosis and/or adenomyoma,” Taiwanese Journal of Obestetrics & Gynecology, vol. 53, no. 4, pp. 459–465, 2014. View at Google Scholar
  55. J. Kulak Jr., C. Fischer, B. Komm, and H. S. Taylor, “Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model,” Endocrinology, vol. 152, no. 8, pp. 3226–3232, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. A. M. Badawy, A. M. Elnashar, and A. A. Mosbah, “Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: A randomized controlled trial,” Acta Obstetricia et Gynecologica Scandinavica, vol. 91, no. 4, pp. 489–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Kimura, K. Takahashi, K. Takebayashi et al., “Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist,” Fertility and Sterility, vol. 87, no. 6, pp. 1468–e9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Kalampokas, M. Kamath, I. Boutas, and E. Kalampokas, “Ulipristal acetate for uterine fibroids: A systematic review and meta-analysis,” Gynecological Endocrinology, vol. 32, no. 2, pp. 91–96, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Donnez and M.-M. Dolmans, “Uterine fibroid management: From the present to the future,” Human Reproduction Update, vol. 22, no. 6, pp. 665–686, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Zhu, Y. Chen, X. Shen, X. Liu, and S.-W. Guo, “Anti-platelet therapy holds promises in treating adenomyosis: Experimental evidence,” Reproductive Biology and Endocrinology, vol. 14, no. 1, article no. 66, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Popovic, S. Puchner, D. Berzaczy, J. Lammer, and R. A. Bucek, “Uterine artery embolization for the treatment of adenomyosis: A review,” Journal of Vascular and Interventional Radiology, vol. 22, no. 7, pp. 901–909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Zhou, L. He, P. Liu et al., “Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: A long-term follow-up study of 252 cases,” PLoS ONE, vol. 11, no. 11, Article ID e0165610, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Dong and Z. Yang, “High-intensity focused ultrasound ablation of uterine localized adenomyosis,” Current Opinion in Obstetrics and Gynecology, vol. 22, no. 4, pp. 326–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Zhou, J.-Y. Chen, L.-D. Tang, W.-Z. Chen, and Z.-B. Wang, “Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: The clinical experience of a single center,” Fertility and Sterility, vol. 95, no. 3, pp. 900–905, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Zhang, W. Zhang, F. Orsi, W. Chen, and Z. Wang, “Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy,” International Journal of Hyperthermia, vol. 31, no. 3, pp. 280–284, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. V. McCausland and A. McCausland, “The response of adenomyosis to endometrial ablation/resection,” Human Reproduction Update, vol. 4, no. 4, pp. 350–359, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Wood, “Surgical and medical treatment of adenomyosis,” Human Reproduction Update, vol. 4, no. 4, pp. 323–336, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. D. R. Phillips, H. G. Nathanson, S. J. Milim, and J. S. Haselkorn, “Laparoscopic bipolar coagulation for the conservative treatment of adenomyomata,” The Journal of Minimally Invasive Gynecology , vol. 4, no. 1, pp. 19–24, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Furuhashi, Y. Miyabe, Y. Katsumata, H. Oda, and N. Imai, “Comparison of complications of vaginal hysterectomy in patients with leiomyomas and in patients with adenomyosis,” Archives of Gynecology and Obstetrics, vol. 262, no. 1-2, pp. 69–73, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. T. G. Stovall, F. W. Ling, and D. A. Crawford, “Hysterectomy for chronic pelvic pain of presumed uterine etiology,” Obstetrics & Gynecology, vol. 75, no. 4, pp. 676–679, 1990. View at Google Scholar · View at Scopus
  71. L. J. Orozco, M. Tristan, M. M. T. Vreugdenhil, and A. Salazar, “Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women,” Cochrane Database of Systematic Reviews, vol. 7, p. CD005638, 2014. View at Google Scholar · View at Scopus
  72. E. C. Evans, K. A. Matteson, F. J. Orejuela et al., “Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review,” Obstetrics & Gynecology, vol. 128, no. 3, pp. 476–485, 2016. View at Publisher · View at Google Scholar · View at Scopus
  73. V. C. Kok, H.-J. Tsai, C.-F. Su, and C.-K. Lee, “The risks for ovarian, endometrial, breast, colorectal, and other cancers in women with newly diagnosed endometriosis or adenomyosis: A population-based study,” International Journal of Gynecological Cancer, vol. 25, no. 6, pp. 968–976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Vercellini, D. Consonni, D. Dridi, B. Bracco, M. P. Frattaruolo, and E. Somigliana, “Uterine adenomyosis and in vitro fertilization outcome: A systematic review and meta-analysis,” Human Reproduction, vol. 29, no. 5, pp. 964–977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Thalluri and K. P. Tremellen, “Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment,” Human Reproduction, vol. 27, no. 12, pp. 3487–3492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. J. M. Puente, A. Fabris, J. Patel et al., “Adenomyosis in infertile women: Prevalence and the role of 3D ultrasound as a marker of severity of the disease,” Reproductive Biology and Endocrinology, vol. 14, no. 1, article no. 60, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. J. R. Nelson and S. L. Corson, “Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: A case report,” Fertility and Sterility, vol. 59, no. 2, pp. 441–443, 1993. View at Publisher · View at Google Scholar · View at Scopus
  78. P. D. Silva, H. E. Perkins, and C. W. Schauberger, “Live birth after treatment of severe adenomyosis with a gonadotropin- releasing hormone agonist,” Fertility and Sterility, vol. 61, no. 1, pp. 171-172, 1994. View at Publisher · View at Google Scholar · View at Scopus
  79. L.-M. Zhou, J. Zheng, Y.-T. Sun, Y.-Y. Zhao, and A.-L. Xia, “Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility,” Zhonghua Fu Chan Ke Za Zhi, vol. 48, no. 5, pp. 334–337, 2013. View at Google Scholar · View at Scopus
  80. T. Tao, S. Chen, X. Chen et al., “Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET),” Nan fang yi ke da xue xue bao = Journal of Southern Medical University, vol. 35, no. 2, pp. 248–251, 2015. View at Google Scholar · View at Scopus
  81. A. Hashimoto, T. Iriyama, and S. Sayama, “Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition,” The Journal of Maternal-fetal Neonatal Medicine, vol. 23, no. 1-6, p. 18, 2017. View at Google Scholar
  82. Z. Niu, Q. Chen, Y. Sun, and Y. Feng, “Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis,” Gynecological Endocrinology, vol. 29, no. 12, pp. 1026–1030, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Moraloglu, E. Tonguc, T. Var, T. Zeyrek, and S. Batioglu, “Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF,” Reproductive BioMedicine Online, vol. 21, no. 3, pp. 338–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. S.-W. Guo, X. Mao, Q. Ma, and X. Liu, “Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis,” Fertility and Sterility, vol. 99, no. 1, pp. 231–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. E. H. Y. Ng, R. H. W. Li, L. Chen, V. T. N. Lan, H. M. Tuong, and S. Quan, “A randomized double blind comparison of atosiban in patients undergoing IVF treatment,” Human Reproduction, vol. 29, no. 12, pp. 2687–2694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. C. Coughlan, W. Ledger, Q. Wang et al., “Recurrent implantation failure: Definition and management,” Reproductive BioMedicine Online, vol. 28, no. 1, pp. 14–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Kishi, M. Yabuta, and F. Taniguchi, “Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility?” Fertility and Sterility, vol. 102, no. 3, pp. 802–e1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. G. F. Grimbizis, T. Mikos, and B. Tarlatzis, “Uterus-sparing operative treatment for adenomyosis,” Fertility and Sterility, vol. 101, no. 2, pp. 472–e8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. A. S. W. Wong, E. C. W. Cheung, K.-T. Leung, S.-W. Yeung, T.-Y. Leung, and T.-Y. Fung, “Transcervical intralesional vasopressin injection in hysteroscopic myomectomy-description of a new technique,” Journal of Laparoendoscopic & Advanced Surgical Techniques, vol. 23, no. 3, pp. 258–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Xu, G. Jamail, M. Xue, X. Guan, and L. Wang, “Removal of Retained Adherent Placental Remnants Using Hysteroscopy Endo-Operative System (HEOS),” Journal of Minimally Invasive Gynecology, vol. 22, no. 6, p. S137, 2015. View at Publisher · View at Google Scholar